<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Nucleic Acids</journal-id><journal-id journal-id-type="publisher-id">JNA</journal-id><journal-title-group><journal-title>Journal of Nucleic Acids</journal-title></journal-title-group><issn pub-type="ppub">2090-0201</issn><issn pub-type="epub">2090-021X</issn><publisher><publisher-name>SAGE-Hindawi Access to Research</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21151658</article-id><article-id pub-id-type="pmc">2997344</article-id><article-id pub-id-type="doi">10.4061/2010/456487</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Aflatoxin B<sub>1</sub>-Associated DNA Adducts Stall S Phase and Stimulate Rad51 foci in <italic>Saccharomyces cerevisiae</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fasullo</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="I1"><sup>1, 2, 3</sup></xref><xref ref-type="aff" rid="I2"/><xref ref-type="aff" rid="I3"/><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yifan</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bortcosh</surname><given-names>William</given-names></name><xref ref-type="aff" rid="I3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Minzeng</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Egner</surname><given-names>Patricia A.</given-names></name><xref ref-type="aff" rid="I4"><sup>4</sup></xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Ordway Research Institute,  Center for Medical Sciences,  150 New Scotland Avenue,  Albany, NY 12209, USA</aff><aff id="I2"><sup>2</sup>Department of Biomedical Sciences,  State University of New York at Albany,  150 New Scotland Avenue, Albany,  NY 12209, USA</aff><aff id="I3"><sup>3</sup>Albany Medical College,  47 New Scotland Avenue,  Albany, NY 12208, USA</aff><aff id="I4"><sup>4</sup>Bloomberg School of Public Health,  Johns Hopkins University,  615 North Wolfe Street, Baltimore,  MD 21205, USA</aff><author-notes><corresp id="cor1">*Michael Fasullo: <email>mfasullo@ordwayresearch.org</email></corresp><fn fn-type="other"><p>Academic Editor: Ashis Basu</p></fn></author-notes><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>2</day><month>12</month><year>2010</year></pub-date><volume>2010</volume><elocation-id>456487</elocation-id><history><date date-type="received"><day>15</day><month>8</month><year>2010</year></date><date date-type="accepted"><day>9</day><month>9</month><year>2010</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2010 Michael Fasullo et al.</copyright-statement><copyright-year>2010</copyright-year><copyright-holder>Copyright &#x000a9; 2010</copyright-holder><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>AFB<sub>1</sub> is a potent recombinagen in budding yeast. AFB<sub>1</sub> exposure induces <italic>RAD51</italic> expression and triggers Rad53 activation in yeast cells that express human CYP1A2. It was unknown, however, when and if Rad51 foci appear. Herein, we show that Rad53 activation correlates with cell-cycle delay in yeast and the subsequent formation of Rad51 foci. In contrast to cells exposed to X-rays, in which Rad51 foci appear exclusively in G2 cells, Rad51 foci in AFB<sub>1</sub>-exposed cells can appear as soon as cells enter S phase. Although <italic>rad51</italic> and <italic>rad4</italic> mutants are mildly sensitive to AFB<sub>1</sub>, chronic exposure of the NER deficient <italic>rad4</italic> cells to AFB<sub>1</sub> leads to increased lag times, while <italic>rad4 rad51</italic> double mutants exhibit synergistic sensitivity and do not grow when exposed to 50&#x02009;<italic>&#x003bc;</italic>M AFB<sub>1</sub>. We suggest  <italic>RAD51</italic> functions to facilitate DNA replication after replication fork stalling or collapse in AFB<sub>1</sub>-exposed cells.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. Introduction</title><p>Hepatocellular carcinoma (HCC) ranks fifth in worldwide cancer mortality (for review, see [<xref ref-type="bibr" rid="B1">1</xref>]) and sixth in the United States [<xref ref-type="bibr" rid="B2">2</xref>]. High-risk factors for HCC include exposure to genotoxins, such as the mycotoxin aflatoxin B<sub>1</sub> (AFB<sub>1</sub>), and infection with hepatitis B and C viruses  [<xref ref-type="bibr" rid="B3">3</xref>]. Exposure to AFB<sub>1</sub> is endemic in particular areas of China and sub-Saharan Africa due to <italic>Aspergillus flavus</italic> (mold) contamination of food and water [<xref ref-type="bibr" rid="B3">3</xref>]. A current hypothesis is that regeneration of liver cells following chronic liver injury renders liver cells susceptible to AFB<sub>1</sub>-associated carcinogenesis [<xref ref-type="bibr" rid="B4">4</xref>].</p><p>HCC pathogenesis is correlated with the accumulation of mutations and chromosomal rearrangements leading to either an inactivation of tumor suppressor genes or activation of oncogenes (for review, see [<xref ref-type="bibr" rid="B5">5</xref>]). MicroRNA-221 (MiR-221) overexpression contributes to liver tumorigenesis [<xref ref-type="bibr" rid="B6">6</xref>] and correlates with downregulation of cyclin dependent kinase inhibitors p21 and p57 [<xref ref-type="bibr" rid="B7">7</xref>]; however, there is no known correlation with AFB<sub>1</sub> exposure. The p53(Ser)249 substitution mutation frequently occurs in liver cancer, where AFB<sub>1</sub> exposure is highest  [<xref ref-type="bibr" rid="B8">8</xref>&#x02013;<xref ref-type="bibr" rid="B10">10</xref>]; however, there are conflicting reports whether the p53 249 codon is a direct hot spot for AFB<sub>1</sub>-associated mutagenesis  [<xref ref-type="bibr" rid="B11">11</xref>]. Gross chromosomal translocations and gene amplifications have also been observed [<xref ref-type="bibr" rid="B12">12</xref>], and 10%&#x02013;20% of HCCs contain cyclin D amplifications [<xref ref-type="bibr" rid="B13">13</xref>]. Although HCC associated with AFB<sub>1</sub> exposure exhibits more genetic instability compared to HCC in nonendemic regions [<xref ref-type="bibr" rid="B14">14</xref>], it is unclear which types of genetic instability are directly caused by AFB<sub>1</sub>-associated DNA damage. </p><p>AFB<sub>1</sub> is not genotoxic <italic>per se</italic> but requires metabolic activation. In humans, AFB<sub>1</sub> metabolic activation in the liver is catalyzed by CYP1A2 and CYP3A4 [<xref ref-type="bibr" rid="B15">15</xref>] to form the highly unstable AFB<sub>1</sub>-8,9-exo-epoxide, which reacts primarily with the N<sup>7</sup> position of guanine, present in the major groove of DNA [<xref ref-type="bibr" rid="B16">16</xref>]. The resulting adduct, 8,9-dihydro-8-(N<sup>7</sup>-guanyl)-9-hydroxyaflatoxin B1 (AFB<sub>1</sub>-N<sup>7</sup>-Guanine) is unstable and converts to either  formamidopyrimidine (FAPY) derivatives or an apurinic site [<xref ref-type="bibr" rid="B16">16</xref>], both potentially mutagenic [<xref ref-type="bibr" rid="B17">17</xref>]. Both the FAPY derivatives and AFB<sub>1</sub>-N<sup>7</sup>-Guanine adducts are repaired by the nucleotide excision repair (NER) genes [<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>]. The FAPY adducts also hinder DNA replication [<xref ref-type="bibr" rid="B20">20</xref>], which could lead to chromosomal breaks and require DNA repair genes that function in double-strand break and X-ray repair (XRCC). Thus, repair of AFB<sub>1</sub>-associated DNA damage may require both NER and XRCC genes. </p><p>Interestingly, a subset of known polymorphisms [<xref ref-type="bibr" rid="B21">21</xref>] in both NER gene XPD and the X-ray repair gene XRCC3 correlate with higher incidence in liver cancer in endemic areas of AFB<sub>1</sub> exposure [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>]. Defective NER could lead to an increase in DNA adducts, while XRCC3 polymorphisms could confer defective repair of double-strand breaks (for review, see [<xref ref-type="bibr" rid="B24">24</xref>]). However, the polymorphism in XRCC3, Thr241Met, which is correlated with higher levels of AFB<sub>1</sub>-associated HCC [<xref ref-type="bibr" rid="B23">23</xref>], has not been correlated with a defect in double-strand break repair [<xref ref-type="bibr" rid="B25">25</xref>], suggesting that other functions in DNA damage or repair may be defective in cells containing this allele. Considering that recombinational repair may also participate in DNA damage-tolerance pathways, it is important to elucidate whether there are competing DNA repair pathways for AFB<sub>1</sub>-associated adducts.</p><p>
				<italic>Saccharomyces cerevisiae</italic> (budding yeast) is useful in elucidating the genetics of DNA repair of AFB<sub>1</sub>-DNA adducts. Yeast strains that express human <italic>CYP1A1</italic> or <italic>CYP1A2</italic> cDNAs on multicopy 2&#x02009;<italic>&#x003bc;</italic> plasmids can measure the genotoxicity of metabolically active carcinogens  [<xref ref-type="bibr" rid="B26">26</xref>&#x02013;<xref ref-type="bibr" rid="B30">30</xref>]. Interestingly, AFB<sub>1</sub> increases recombination frequencies more than mutation frequencies in cells expressing these cDNAs [<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B29">29</xref>]. </p><p>The genotoxicity of AFB<sub>1</sub> in yeast [<xref ref-type="bibr" rid="B26">26</xref>&#x02013;<xref ref-type="bibr" rid="B29">29</xref>] correlates with the transcription of DNA repair genes involved in recombination, including <italic>RAD51</italic> [<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B30">30</xref>] and <italic>RAD54</italic> [<xref ref-type="bibr" rid="B30">30</xref>]. <italic>RAD51 </italic>induction has been observed in log phase cells exposed to AFB<sub>1</sub> [<xref ref-type="bibr" rid="B30">30</xref>], and <italic>RAD51</italic> overexpression partially suppresses recombination defects in the <italic>mec1</italic> null checkpoint mutant [<xref ref-type="bibr" rid="B27">27</xref>]. <italic>RAD51</italic> is also required for AFB<sub>1</sub>-associated sister chromatid exchange (SCE) [<xref ref-type="bibr" rid="B29">29</xref>]. These results indicate that increased expression of <italic>RAD51 </italic>likely stimulates recombination when cells are exposed to AFB<sub>1</sub>-associated DNA adducts. </p><p>In log-phase yeast cultures, AFB<sub>1</sub> is a mutagen [<xref ref-type="bibr" rid="B28">28</xref>]. Microarray analysis reveals not only a strong induction of<italic> RAD51 </italic>and <italic>RAD54</italic> but also a downregulation of gene transcripts encoding histones [<xref ref-type="bibr" rid="B30">30</xref>]. <italic>rad51</italic> mutants exhibit an increase in AFB<sub>1 </sub>-associated mutations [<xref ref-type="bibr" rid="B28">28</xref>]. Both AFB<sub>1</sub>-associated mutations and recombination events require checkpoint genes [<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>].  Considering that AFB<sub>1</sub>  exposure triggers both checkpoint activation and S phase delay, it seems possible that the genotoxic responses to AFB<sub>1</sub> result from stalled replication forks.</p><p>In this paper, we show that Rad53 activation correlates with S phase delay and subsequent Rad51 foci formation in yeast. A <italic>RAD51</italic> deletion in NER defective strains results in high levels of lethality. We suggest that Rad51 foci formation may occur in S phase and be associated with error-free bypass of DNA lesions.</p></sec><sec sec-type="section" id="sec2"><title>2. Materials and Methods</title><sec sec-type="subsection" id="sec2.1"><title>2.1. Strains and Media</title><p>Standard media were used for the culture of yeast cells. YPD (yeast extract, peptone, and dextrose), SC-TRP (synthetic complete lacking tryptophan), and SC-URA (synthetic complete lacking uracil) and FOA (5-fluro-orotic acid) were described in Burke et al. [<xref ref-type="bibr" rid="B31">31</xref>]. The genotypes of yeast strains used in this study are listed in <xref ref-type="table" rid="tab1">Table 1</xref>.  <italic>rad4</italic>, <italic>rad51</italic> and <italic>rad4 rad51 </italic>strains for measuring SCE and AFB<sub>1</sub> sensitivity are derived from YB163, which contains <italic>his3</italic> recombination substrates in tandem at <italic>TRP1 </italic>[<xref ref-type="bibr" rid="B32">32</xref>]. Ura<sup>&#x02212;</sup> derivatives of <italic>rad4</italic>, and <italic>rad4 rad51</italic> strains were selected on FOA medium. LSY1957 was a gift of Fung et al. [<xref ref-type="bibr" rid="B33">33</xref>].  pRS424-CYP1A2 was constructed by inserting the <italic>Sac</italic>I CYP1A2 fragment from pCS316 into pRS424 and introduced into yeast strains by selecting for Trp<sup>+</sup> transformants.</p></sec><sec sec-type="subsection" id="sec2.2"><title>2.2. Measuring DNA AFB<sub>1</sub>-Associated Recombination and Rad51 foci</title><p>To measure AFB<sub>1</sub>-associated genotoxic events, log-phase yeast cells (A<sub>600</sub> = 0.5&#x02013;1) were centrifuged and concentrated five-fold in selective media (SC-URA or SC-TRP). Cells were exposed to 50&#x02009;<italic>&#x003bc;</italic>M AFB<sub>1</sub>, previously dissolved in DMSO. To synchronize cells in G1, log-phase cells were exposed to 10<sup>&#x02212;4</sup>&#x02009;M alpha factor (Sigma Co.) for two hours, and G1 cells were visualized in the light microscope. Cells were maintained in selective media (SC-URA or SC-TRP) during the carcinogen exposure and then washed twice in H<sub>2</sub>O. To measure SCE frequencies, recombinants were selected on SC-HIS, and viability was determined by plating an appropriate dilution on YPD. To visualize Rad51 foci formation, cells were resuspended in selective media (SC-TRP or SC-URA) and immobilized on glass slides.</p><p>To determine whether ionizing radiation stimulates the formation of Rad51 foci, cells were washed once in H<sub>2</sub>O, resuspended in 10&#x02009;ml of H<sub>2</sub>O, and placed in a 81&#x02009;mm diameter Petri dish. Cells were irradiated at 6&#x02009;krad using a Nordion 1.8&#x02009;kCi <sup>137</sup>Cs irradiator (6&#x02009;krad/hr). After irradiation cells were concentrated in YPD medium and immobilized on glass slides.</p></sec><sec sec-type="subsection" id="sec2.3"><title>2.3. Live Cell Epifluorecence and Microscopy Analysis</title><p>Cells for microscopic analysis were grown to early-mid-log phase overnight in synthetic medium. After exposure to the genotoxin, cells were harvested by centrifugation, washed twice, and resuspended in YPD. Immobilization of cells was performed by mixing equal volumes of cell suspension and 1.4% low-melt agarose. Cover slips were sealed with a wax mixture as described by Lisby et al. [<xref ref-type="bibr" rid="B34">35</xref>]. Slides were visualized using a Zeiss LSM 510&#x02009;META confocal microscope.</p></sec><sec sec-type="subsection" id="sec2.4"><title>2.4. FACS Analyses</title><p>Cells were visualized by the fluorescent activated cell sorter (FACS) to directly correlate their DNA content with their cell-cycle phases.  After AFB<sub>1</sub>  exposure, cells were washed, resuspended in 0.1&#x02009;M sodium citrate, and treated with 1&#x02009;mg/ml RNase A at 50&#x000b0;C for 1&#x02009;hr.  The cells were incubated at 50&#x000b0;C for 5&#x02009;hr in 8&#x02009;<italic>&#x003bc;</italic>g/ml proteinase K. An equal volume of 25&#x02009;<italic>&#x003bc;</italic>g/ml propidium iodide (PI) diluted in 0.1&#x02009;M sodium citrate was then added to the cells prior to the FACS analysis, to a final concentration of 12.5&#x02009;<italic>&#x003bc;</italic>g/ml PI, and analyzed for fluorescence content with the use of a BD LSR II Flow cytometer.</p></sec><sec sec-type="subsection" id="sec2.5"><title>2.5. Detection and Quantification of DNA Adducts</title><p>To measure the AFB<sub>1</sub>-associated DNA adducts in yeast, we used liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI/MS/MS) [<xref ref-type="bibr" rid="B35">36</xref>]. Log-phase cultures of yeast-expressing human CYP1A2 (pCS316) were exposed to 50&#x02009;<italic>&#x003bc;</italic>M AFB<sub>1</sub> for 4&#x02009;h. Because standard protocols for isolating yeast DNA involve alkaline buffers, rendering the highly unstable AFB<sub>1</sub>-N<sup>7</sup>-Guanine DNA adducts labile, we have modified the &#x0201c;smash-and-grab&#x0201d; protocol [<xref ref-type="bibr" rid="B36">37</xref>] so that we are using a neutral buffer containing 10&#x02009;mM Tris-HCl, 1&#x02009;mM EDTA, 100&#x02009;mM NaCl, 2% Triton X-100, and 1% SDS, pH 7. DNA was isolated from two independent samples of yeast cells. The DNA adducts were identified and measured by high-performance liquid chromatography and tandem mass spectroscopy (LC-ESI/MS/MS) after acid hydrolysis [<xref ref-type="bibr" rid="B35">36</xref>].</p></sec><sec sec-type="subsection" id="sec2.6"><title>2.6. Determining Rad53 Activation</title><p>Activation of Rad53 was determined by Western blots. Cells were inoculated in SC-URA medium. Log-phase cells (A<sub>600</sub> = 0.5&#x02013;1) were concentrated three fold in SC-URA and exposed to 50&#x02009;<italic>&#x003bc;</italic>M AFB<sub>1</sub> for 4&#x02009;h. After washing cells twice in H<sub>2</sub>O, aliquots were plated directly on SC-HIS to measure recombination, appropriately diluted and plated on YPD to measure viability. Protein extracts were prepared as previously described by Foiani et al. [<xref ref-type="bibr" rid="B37">38</xref>], separated on 10% acrylamide/0.266% bis-acrylamide gels for Rad53 detection and transferred to nitrocellulose membranes. Rad53 was detected by Western blotting using goat anti-Rad53 (yC-19, Santa Cruz, Biotechnology,  Santa Cruz, CA). The secondary antibody was antigoat IgG-HRP (Santa Cruz). </p></sec></sec><sec sec-type="section" id="sec3"><title>3. Results</title><sec sec-type="subsection" id="sec3.1"><title>3.1. Delay in Cell-Cycle Progression Correlated with Rad53 Activation</title><p>We previously observed that log-phase cells exposed to AFB<sub>1</sub> exhibit Rad53 activation [<xref ref-type="bibr" rid="B29">29</xref>], which can result from replication blockage or delay. We measured Rad53 activation and cell-cycle delay in log-phase cells after continuous exposure to 50&#x02009;<italic>&#x003bc;</italic>M AFB<sub>1</sub>. The data show that there is a peak activation of Rad53 after 3&#x02009;hrs exposure to AFB<sub>1</sub>. Three hrs of exposure was also sufficient time to observe SCE recombinants (<xref ref-type="fig" rid="fig1">Figure 1</xref>). After 4&#x02009;hrs of AFB<sub>1</sub> exposure, there was less Rad53 activation and cell-cycle progression continued. The transient delay in the cell cycle is consistent with a previous study that indicated that AFB<sub>1</sub>-exposed yeast exhibit a transient S phase delay  [<xref ref-type="bibr" rid="B30">30</xref>]. The data suggest that there is a correlation between AFB<sub>1</sub>-associated Rad53 activation and S phase delay. Because AFB<sub>1</sub> adducts are detected in cycling cells after the S phase delay [<xref ref-type="bibr" rid="B29">29</xref>], we speculate that cells actively tolerate AFB<sub>1</sub>-associated DNA lesions during DNA replication. </p><p>Rad53 not only delays cell-cycle progression but is also required for the phosphorylation of the Rad51 paralogs, Rad55, and Rad57, which may facilitate replication restart at stalled replication forks [<xref ref-type="bibr" rid="B38">39</xref>].  Rad55 and Rad57 facilitate the formation of DNA repair foci at double-strand breaks [<xref ref-type="bibr" rid="B39">40</xref>]. Previous data indicate that RAD53 is required for DNA damage associated SCE [<xref ref-type="bibr" rid="B40">41</xref>], including AFB<sub>1</sub>-associated SCE  [<xref ref-type="bibr" rid="B29">29</xref>]. We, therefore, determined whether AFB<sub>1</sub> exposure also stimulates Rad51 foci formation in yeast.</p></sec><sec sec-type="subsection" id="sec3.2"><title>3.2. Exposure to AFB<sub>1</sub> Results in Rad51 foci Formation in Cells that Are Entering S Phase</title><p>To visualize Rad51 foci that result from AFB<sub>1</sub>-associated DNA damage, we introduced pRS424-CYP1A2 into strain LSY1957 [<xref ref-type="bibr" rid="B33">33</xref>] to metabolically activate AFB<sub>1</sub>. This strain (YB405) contains <italic>rad51-I345T</italic>, an allele of<italic> RAD51</italic>, which when tagged with YFP, is still capable of conferring radiation resistance [<xref ref-type="bibr" rid="B33">33</xref>]. As a positive control, cells were exposed to either X rays (2 krad) or gamma rays (6 krads). After exposure, cells were returned to growth medium (YPD), and live cells were imaged for Rad51 foci. After 2&#x02009;hrs of growth in YPD, most irradiated cells arrested in G2 and exhibited the dumb-bell shape (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Cells were then visualized with the confocal microscope. Nearly 90% of the G2-arrested cells contain Rad51 foci, in agreement with Lisby et al. [<xref ref-type="bibr" rid="B39">40</xref>]. </p><p>Similarly, we determined whether Rad51 foci appear in cells after exposure to 50&#x02009;<italic>&#x003bc;</italic>M AFB<sub>1</sub> for 3&#x02009;hrs. To first confirm the presence of AFB<sub>1</sub>  adducts, we extracted DNA from LSY197 cells after AFB<sub>1</sub> exposure and observed approximately the same number of DNA adducts (<xref ref-type="table" rid="tab2">Table 2</xref>) as previously observed in strains used to measure recombination [<xref ref-type="bibr" rid="B29">29</xref>]. After 3&#x02009;hr of AFB<sub>1</sub> exposure, we also observed that nearly 90% of the cells exhibited Rad51 foci. However, the difference with irradiated cells was that many AFB<sub>1</sub>-exposed cells that exhibited Rad51 foci were not G2 arrested. In addition, many cells exhibited Rad51 foci in both mother and daughter bud (<xref ref-type="fig" rid="fig2">Figure 2</xref>). These data indicate that AFB<sub>1</sub>-associated Rad51 foci are not restricted to the G2 phase of the cell cycle. Because daughter buds are not always visible in the confocal microscope, we decided to synchronize cells in G1, expose the cells to AFB<sub>1</sub> and then determine when Rad51 foci could be detected. </p><p>To determine whether cells can express Rad51 foci in S phase, cells were first arrested in G1 with alpha factor, and then exposed to AFB<sub>1</sub> for three hours. Cells were then washed and returned to growth medium without AFB<sub>1</sub>. We observed that newly budded cells (90%) contain Rad51 foci. Rad51 foci were not evident after 30 minutes or 1&#x02009;hr incubation time, but were evident after 1.5&#x02009;hrs of incubation; after three hours of incubation, there were few Rad51 foci. These data indicate that Rad51 foci can be observed in cycling cells that are entering S phase.</p></sec><sec sec-type="subsection" id="sec3.3"><title>3.3. <italic>rad4</italic> Cells Are Defective in the Excision of AFB<sub>1</sub> DNA Adducts</title><p>NER and recombinational repair mutants are modestly sensitive to AFB<sub>1 </sub>[<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>]. Both <italic>rad4</italic> and <italic>rad51 </italic>mutants exhibit higher rates of AFB<sub>1</sub>-associated mutagenesis [<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>]. Measurements of DNA adducts indicated there are about three-fold higher levels of AFB<sub>1</sub>-N<sup>7</sup>-Guanine adducts in <italic>rad4</italic>, compared to wild type (<xref ref-type="table" rid="tab2">Table 2</xref>). Consistent with the notion that AFB<sub>1</sub> adducts persist longer in <italic>rad4 </italic>mutants, we observed by FACS analysis a delayed S phase after exposure to 10&#x02009;<italic>&#x003bc;</italic>M AFB<sub>1</sub>. We asked whether wild type, <italic>rad4</italic>, and <italic>rad51</italic> mutants could tolerate DNA adducts. </p><p>We used a growth assay in microtiter dishes  [<xref ref-type="bibr" rid="B41">42</xref>] to determine differences in growth curves of wild type (YB401), <italic>rad4</italic> (YB403), <italic>rad51</italic>(YB402), and <italic>rad4 rad51</italic> (YB404) strains during chronic exposure to AFB<sub>1</sub>. Approximately 10<sup>5</sup> cells were inoculated in 96 well plates and exposed to 0&#x02009;<italic>&#x003bc;</italic>M, 25&#x02009;<italic>&#x003bc;</italic>M and 50&#x02009;<italic>&#x003bc;</italic>M of AFB<sub>1</sub>; the experiments were done in triplicate. Growth was measured by <italic>A</italic><sub>600</sub> (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The lag time [<xref ref-type="bibr" rid="B41">42</xref>] for wild type was ~3&#x02009;hrs and similar to <italic>rad51</italic>. Whereas the <italic>rad4 </italic>mutants exhibited a longer lag period, ~13&#x02009;hrs, the <italic>rad4 rad51</italic> mutant exhibited little, if any, growth. The data suggest that <italic>RAD51</italic> function is critical in conferring AFB<sub>1</sub> resistance in the <italic>rad4 </italic>mutant. This result is consistent with previous results that <italic>rad14 rad51</italic> cells are also synergistically more sensitive to AFB<sub>1</sub> [<xref ref-type="bibr" rid="B30">30</xref>].</p><p>To further investigate whether <italic>rad4 </italic>cells can progress through S phase in the presence of DNA adducts, we arrested <italic>rad4</italic> cells in G1 with alpha factor and exposed cells to AFB<sub>1</sub> for 3&#x02009;hrs.  Cells were then washed, diluted, and inoculated on YPD plates to visualize the growth of single colonies every three hours under the microscope. After 12&#x02009;hrs, ~70% (46/67) of cells that were not exposed to AFB<sub>1</sub> formed colonies. However, only ~16% (46/268) of cells exposed to AFB<sub>1</sub> (10&#x02009;<italic>&#x003bc;&#x0039c;</italic> or 50&#x02009;<italic>&#x003bc;&#x0039c;</italic>) formed colonies. 60% (<italic>n</italic> = 2) of either wild type or <italic>rad4</italic> cells that do form colonies retain the <italic>URA3</italic>-containing plasmid expressing CYP1A2, indicating that colony formation occurred in cells that could still metabolically activate AFB<sub>1</sub>. Many of the <italic>rad4 </italic>cells that do not form colonies were arrested in early S phase, as evident by the presence of small daughter buds (<xref ref-type="fig" rid="fig3">Figure 3(f)</xref>).  These data indicate that a few NER-deficient cells can progress through the cell cycle in the presence of AFB<sub>1</sub>-associated DNA adducts.</p></sec></sec><sec sec-type="section" id="sec4"><title>4. Discussion</title><p>AFB<sub>1</sub> is a very potent liver carcinogen. The metabolic activation of AFB<sub>1</sub> generates AFB<sub>1</sub>-associated DNA adducts which both stimulate mutagenesis and recombination in a variety of organisms. Polymorphisms in both XPD and XRCC3 are correlated with greater HCC risk  [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>], thus underscoring the need to elucidate the role of recombinational repair in AFB<sub>1</sub> metabolism. In budding yeast, well-conserved RAD and checkpoint genes are required for AFB<sub>1</sub>-associated mutation and recombination  [<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>]. Higher frequencies of AFB<sub>1</sub>-associated mutations in <italic>rad51</italic> mutants  [<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>] and synergistic increase in the AFB<sub>1</sub> sensitivity of double mutants defective in both recombinational and NER suggest that there are redundant pathways in conferring resistance to AFB<sub>1</sub>. AFB<sub>1</sub> is highly recombinogenic and induces <italic>RAD51</italic> in yeast [<xref ref-type="bibr" rid="B27">27</xref>]; however, it was unclear when and if Rad51 foci form.  The salient conclusions from this study are (1) cells are delayed in S phase after AFB<sub>1</sub> exposure, and there is a correlation with Rad53 checkpoint activation and cell cycle delay; (2) Rad51 foci form after AFB<sub>1</sub>-exposed cells enter S phase; (3) <italic>rad4 </italic>mutants accumulate AFB<sub>1</sub>-N<sup>7</sup>-Guanine adducts, and many exposed cells arrest or are delayed in S phase. This is the first study to show that AFB<sub>1</sub> exposure leads to Rad51 foci formation.</p><p>Previous studies indicated that <italic>RAD53</italic> is required for both AFB<sub>1</sub>-associated recombination and mutagenesis in yeast [<xref ref-type="bibr" rid="B29">29</xref>]. The coincident timing of recombination, Rad53 checkpoint activation, and S phase delay suggest that checkpoint activation is required to trigger AFB<sub>1</sub>-associated recombination in yeast. A possible link is that Rad53 is required for the DNA damage-associated phosphorylation of the Rad51 paralogs Rad55 and Rad57  [<xref ref-type="bibr" rid="B38">39</xref>], which participate in recombinational repair between sister chromatids  [<xref ref-type="bibr" rid="B42">34</xref>]. We do not yet know how the checkpoint activation would trigger mutagenesis, but several studies suggest a role for checkpoint genes in DNA damage tolerance and translesion synthesis  [<xref ref-type="bibr" rid="B43">43</xref>&#x02013;<xref ref-type="bibr" rid="B46">46</xref>]. </p><p>The identification of AFB<sub>1</sub>-associated Rad51 foci was performed by detecting YFP fluorescence in the confocal microscope. Rad51 is not known to bind to specific DNA adducts, so we presume that the AFB<sub>1</sub> N<sup>7</sup>-Guanine adducts and resulting FAPY and apurinic sites are further converted into recombinogenic lesions, including double-strand breaks or single-strand gaps. It is unlikely that all the lesions that initiate AFB<sub>1</sub>-associated Rad51 foci are the same as for X-ray-associated Rad51 foci, since we observed Rad51 foci in newly cycling cells entering S phase whereas we only observed X-ray-initiated Rad51-foci in G2-arrested cells. However, double-strand breaks or single-strand gaps could also result after replication forks stall or collapse in S phase, and AFB<sub>1</sub> lesions have been reported to stall or hinder DNA replication in <italic>Escherichia coli</italic>  [<xref ref-type="bibr" rid="B17">17</xref>]. Thus, an attractive model is that Rad51 foci form as AFB<sub>1</sub>-exposed cells transition through S phase. </p><p>We suggest that <italic>RAD51</italic> confers AFB<sub>1</sub> resistance in NER defective mutants by two possible functions. First, <italic>RAD51</italic> would function in repairing double-strand breaks that indirectly results from AFB<sub>1</sub>-associated DNA damage. Considering that one double-strand break could confer lethality [<xref ref-type="bibr" rid="B47">47</xref>], one would estimate that at least one break occurs in every <italic>rad4 rad51</italic> double mutant cell during chronic exposure to 50&#x02009;<italic>&#x003bc;</italic>M AFB<sub>1</sub>. Second, <italic>RAD51</italic> could actively participate in tolerating AFB<sub>1</sub>-associated DNA lesions; previous studies have indicated that the <italic>RAD52</italic> pathway is involved in tolerating UV-associated damage [<xref ref-type="bibr" rid="B48">48</xref>]. Growth curves of wild-type cells indicate that some AFB<sub>1</sub>-associated DNA adducts can be tolerated without affecting doubling time. This second possibility is supported by observations that <italic>rad14 rad51</italic> mutants exhibit extremely high frequencies of AFB<sub>1</sub>-associated mutagenesis  [<xref ref-type="bibr" rid="B28">28</xref>]. Further speculation would suggest that the Rad51-paralog, XRCC3, has a similar function.</p></sec><sec sec-type="section" id="sec5"><title>5. Conclusions</title><p>AFB<sub>1</sub>-associated DNA adducts stimulate both checkpoint activation and Rad51 focus formation. The timing of the Rad51 foci during the cell cycle in early S phase suggests a different mechanism of foci formation, compared to that of ionizing radiation.  Understanding the function of these Rad51 foci will elucidate how polymorphisms in XRCC3 correlate with higher rates of liver cancer in endemic areas exposed to AFB<sub>1</sub>. It will thus be interesting if Rad51 foci also occur in mammalian cells after AFB<sub>1</sub> exposure.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by Grants nos. ES015954 and PO1ES006052 from the National Institutes of Health. The authors are thankful to Gary Schools for his expertise on the confocal microscope, Autumn Smith and Cinzia Cera for assistance with the microplate reader, and Cinzia Cera for critically reading this paper.  We thank Chang-Uk Lim for assistance with the flow cytometer.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>SA</given-names></name><name><surname>Ferry</surname><given-names>DR</given-names></name><name><surname>El-Gazzaz</surname><given-names>G</given-names></name><etal/></person-group><article-title>Hepatocellular carcinoma</article-title><source><italic>Annals of Oncology</italic></source><year>2001</year><volume>12</volume><issue>2</issue><fpage>161</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">11300318</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jemal</surname><given-names>A</given-names></name><name><surname>Siegael</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Ward</surname><given-names>E</given-names></name></person-group><article-title>Cancer statistics</article-title><source><italic>CA A Cancer Journal for Clinicians</italic></source><year>2010</year><volume>60</volume><issue>5</issue><fpage>277</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">20610543</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGlynn</surname><given-names>KA</given-names></name><name><surname>London</surname><given-names>WT</given-names></name></person-group><article-title>Epidemiology and natural history of hepatocellular carcinoma</article-title><source><italic>Best Practice and Research</italic></source><year>2005</year><volume>19</volume><issue>1</issue><fpage>3</fpage><lpage>23</lpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kew</surname><given-names>MC</given-names></name></person-group><article-title>Synergistic interaction between aflatoxin B<sub>1</sub> and hepatitis B virus in hepatocarcinogenesis</article-title><source><italic>Liver International</italic></source><year>2003</year><volume>23</volume><issue>6</issue><fpage>405</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">14986813</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradpour</surname><given-names>D</given-names></name><name><surname>Blum</surname><given-names>HE</given-names></name></person-group><article-title>Pathogenesis of hepatocellular carcinoma</article-title><source><italic>European Journal of Gastroenterology and Hepatology</italic></source><year>2005</year><volume>17</volume><issue>5</issue><fpage>477</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">15827436</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pineau</surname><given-names>P</given-names></name><name><surname>Volinia</surname><given-names>S</given-names></name><name><surname>McJunkin</surname><given-names>K</given-names></name><etal/></person-group><article-title>miR-221 overexpression contributes to liver tumorigenesis</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2010</year><volume>107</volume><issue>1</issue><fpage>264</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">20018759</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornari</surname><given-names>F</given-names></name><name><surname>Gramantieri</surname><given-names>L</given-names></name><name><surname>Ferracin</surname><given-names>M</given-names></name><etal/></person-group><article-title>MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma</article-title><source><italic>Oncogene</italic></source><year>2008</year><volume>27</volume><issue>43</issue><fpage>5651</fpage><lpage>5661</lpage><pub-id pub-id-type="pmid">18521080</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>IC</given-names></name><name><surname>Metcalf</surname><given-names>RA</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Welsh</surname><given-names>JA</given-names></name><name><surname>Wang</surname><given-names>NJ</given-names></name><name><surname>Harris</surname><given-names>CC</given-names></name></person-group><article-title>Mutational hotspot in the p53 gene in human hepatocellular carcinomas</article-title><source><italic>Nature</italic></source><year>1991</year><volume>350</volume><issue>6317</issue><fpage>427</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">1849234</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>H-M</given-names></name><name><surname>Ong</surname><given-names>C-N</given-names></name></person-group><article-title>Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis</article-title><source><italic>Mutation Research</italic></source><year>1996</year><volume>366</volume><issue>1</issue><fpage>23</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">8921985</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wogan</surname><given-names>GN</given-names></name></person-group><article-title>Aflatoxin as a human carcinogen</article-title><source><italic>Hepatology</italic></source><year>1999</year><volume>30</volume><issue>2</issue><fpage>573</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">10421671</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paget</surname><given-names>V</given-names></name><name><surname>Sichel</surname><given-names>F</given-names></name><name><surname>Garon</surname><given-names>D</given-names></name><name><surname>Lechevrel</surname><given-names>M</given-names></name></person-group><article-title>Aflatoxin B<sub>1</sub>-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast)</article-title><source><italic>Mutation Research</italic></source><year>2008</year><volume>656</volume><issue>1-2</issue><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">18725321</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimonjic</surname><given-names>DB</given-names></name><name><surname>Durkin</surname><given-names>ME</given-names></name><name><surname>Keck-Waggoner</surname><given-names>CL</given-names></name><name><surname>Park</surname><given-names>S-W</given-names></name><name><surname>Thorgeirsson</surname><given-names>SS</given-names></name><name><surname>Popescu</surname><given-names>NC</given-names></name></person-group><article-title>SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma</article-title><source><italic>Neoplasia</italic></source><year>2003</year><volume>5</volume><issue>5</issue><fpage>390</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">14670176</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>E</given-names></name><name><surname>Wong</surname><given-names>N</given-names></name><name><surname>Lai</surname><given-names>PB-S</given-names></name><name><surname>To</surname><given-names>K-F</given-names></name><name><surname>Lau</surname><given-names>W-Y</given-names></name><name><surname>Johnson</surname><given-names>PJ</given-names></name></person-group><article-title>Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines</article-title><source><italic>Genes Chromosomes and Cancer</italic></source><year>2002</year><volume>33</volume><issue>2</issue><fpage>150</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">11793441</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pineau</surname><given-names>P</given-names></name><name><surname>Marchio</surname><given-names>A</given-names></name><name><surname>Battiston</surname><given-names>C</given-names></name><etal/></person-group><article-title>Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure</article-title><source><italic>Mutation Research</italic></source><year>2008</year><volume>653</volume><issue>1-2</issue><fpage>6</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">18467159</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eaton</surname><given-names>DL</given-names></name><name><surname>Gallagher</surname><given-names>EP</given-names></name></person-group><article-title>Mechanisms of aflatoxin carcinogenesis</article-title><source><italic>Annual Review of Pharmacology and Toxicology</italic></source><year>1994</year><volume>34</volume><fpage>135</fpage><lpage>172</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>CN</given-names></name><name><surname>Garner</surname><given-names>RC</given-names></name></person-group><article-title>Aflatoxin B oxide generated by chemical or enzymic oxidation of aflatoxin B<sub>1</sub> causes guanine substitution in nucleic acids</article-title><source><italic>Nature</italic></source><year>1977</year><volume>267</volume><issue>5614</issue><fpage>863</fpage><lpage>865</lpage><pub-id pub-id-type="pmid">895848</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smela</surname><given-names>ME</given-names></name><name><surname>Hamm</surname><given-names>ML</given-names></name><name><surname>Henderson</surname><given-names>PT</given-names></name><name><surname>Harris</surname><given-names>CM</given-names></name><name><surname>Harris</surname><given-names>TM</given-names></name><name><surname>Essigmann</surname><given-names>JM</given-names></name></person-group><article-title>The aflatoxin B<sub>1</sub> formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2002</year><volume>99</volume><issue>10</issue><fpage>6655</fpage><lpage>6660</lpage><pub-id pub-id-type="pmid">12011430</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alekseyev</surname><given-names>YO</given-names></name><name><surname>Hamm</surname><given-names>ML</given-names></name><name><surname>Essigmann</surname><given-names>JM</given-names></name></person-group><article-title>Aflatoxin B<sub>1</sub> formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo</article-title><source><italic>Carcinogenesis</italic></source><year>2004</year><volume>25</volume><issue>6</issue><fpage>1045</fpage><lpage>1051</lpage><pub-id pub-id-type="pmid">14742311</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedard</surname><given-names>LL</given-names></name><name><surname>Massey</surname><given-names>TE</given-names></name></person-group><article-title>Aflatoxin B<sub>1</sub>-induced DNA damage and its repair</article-title><source><italic>Cancer Letters</italic></source><year>2006</year><volume>241</volume><issue>2</issue><fpage>174</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">16458422</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>KL</given-names></name><name><surname>Voehler</surname><given-names>MW</given-names></name><name><surname>Magee</surname><given-names>SM</given-names></name><name><surname>Harris</surname><given-names>CM</given-names></name><name><surname>Harris</surname><given-names>TM</given-names></name><name><surname>Stone</surname><given-names>MP</given-names></name></person-group><article-title>Structural perturbations induced by the <italic>&#x003b1;</italic>-anomer of the aflatoxin B<sub>1</sub> formamidopyrimidine adduct in duplex and single-strand DNA</article-title><source><italic>Journal of the American Chemical Society</italic></source><year>2009</year><volume>131</volume><issue>44</issue><fpage>16096</fpage><lpage>16107</lpage><pub-id pub-id-type="pmid">19831353</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manuguerra</surname><given-names>M</given-names></name><name><surname>Saletta</surname><given-names>F</given-names></name><name><surname>Karagas</surname><given-names>MR</given-names></name><etal/></person-group><article-title>XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review</article-title><source><italic>American Journal of Epidemiology</italic></source><year>2006</year><volume>164</volume><issue>4</issue><fpage>297</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">16707649</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>XD</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Qu</surname><given-names>DY</given-names></name><etal/></person-group><article-title>The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China</article-title><source><italic>Annals of Epidemiology</italic></source><year>2008</year><volume>18</volume><issue>7</issue><fpage>572</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">18504145</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>XD</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>YF</given-names></name><etal/></person-group><article-title>XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk</article-title><source><italic>BMC Cancer</italic></source><year>2009</year><volume>17</volume><issue>9, article no. 400</issue></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>RD</given-names></name><name><surname>Jasin</surname><given-names>M</given-names></name></person-group><article-title>Double-strand-break-induced homologous recombination in mammalian cells</article-title><source><italic>Biochemical Society Transactions</italic></source><year>2001</year><volume>29</volume><issue>2</issue><fpage>196</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">11356153</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araujo</surname><given-names>FD</given-names></name><name><surname>Pierce</surname><given-names>AJ</given-names></name><name><surname>Stark</surname><given-names>JM</given-names></name><name><surname>Jasin</surname><given-names>M</given-names></name></person-group><article-title>Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks</article-title><source><italic>Oncogene</italic></source><year>2002</year><volume>21</volume><issue>26</issue><fpage>4176</fpage><lpage>4180</lpage><pub-id pub-id-type="pmid">12037675</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengstag</surname><given-names>C</given-names></name><name><surname>Weibel</surname><given-names>B</given-names></name><name><surname>Fasullo</surname><given-names>M</given-names></name></person-group><article-title>Genotoxicity of aflatoxin B<sub>1</sub>: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae</article-title><source><italic>Cancer Research</italic></source><year>1996</year><volume>56</volume><issue>23</issue><fpage>5457</fpage><lpage>5465</lpage><pub-id pub-id-type="pmid">8968101</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller-Seitz</surname><given-names>MU</given-names></name><name><surname>Certa</surname><given-names>U</given-names></name><name><surname>Sengstag</surname><given-names>C</given-names></name><name><surname>W&#x000fc;rgler</surname><given-names>FE</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Fasullo</surname><given-names>M</given-names></name></person-group><article-title>Transcriptional response of yeast to aflatoxin B<sub>1</sub>: recombinational repair involving RAD51 and RAD1</article-title><source><italic>Molecular Biology of the Cell</italic></source><year>2004</year><volume>15</volume><issue>9</issue><fpage>4321</fpage><lpage>4336</lpage><pub-id pub-id-type="pmid">15215318</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Breeden</surname><given-names>LL</given-names></name><name><surname>Zarbl</surname><given-names>H</given-names></name><name><surname>Preston</surname><given-names>BD</given-names></name><name><surname>Eaton</surname><given-names>DL</given-names></name></person-group><article-title>Expression of a human cytochrome P450 in yeast permits analysis of pathways for response to and repair of aflatoxin-induced DNA damage</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2005</year><volume>25</volume><issue>14</issue><fpage>5823</fpage><lpage>5833</lpage><pub-id pub-id-type="pmid">15988000</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasullo</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Egner</surname><given-names>P</given-names></name></person-group><article-title>Stimulation of sister chromatid exchanges and mutation by aflatoxin B<sub>1</sub>-DNA adducts in <italic>Saccharomyces cerevisiae</italic> requires <italic>MEC1</italic> (ATR), <italic>RAD53</italic>, and <italic>DUN1</italic></article-title><source><italic>Molecular Carcinogenesis</italic></source><year>2008</year><volume>47</volume><issue>8</issue><fpage>608</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">18228255</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Breeden</surname><given-names>LL</given-names></name><name><surname>Fan</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>LP</given-names></name><name><surname>Eaton</surname><given-names>DL</given-names></name><name><surname>Zarbl</surname><given-names>H</given-names></name></person-group><article-title>Analysis of cellular responses to aflatoxin B<sub>1</sub> in yeast expressing human cytochrome P450 1A2 using cDNA microarrays</article-title><source><italic>Mutation Research</italic></source><year>2006</year><volume>593</volume><issue>1-2</issue><fpage>121</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">16122766</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>D</given-names></name><name><surname>Dawson</surname><given-names>D</given-names></name><name><surname>Stearns</surname><given-names>T</given-names></name></person-group><source><italic>A Cold Spring Harbor Laboratory Course Manual</italic></source><year>2000</year><publisher-loc>New York, NY, USA</publisher-loc><publisher-name>Cold Spring Harbor Press</publisher-name><series>Methods in Yeast Genetics</series></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasullo</surname><given-names>MT</given-names></name><name><surname>Davis</surname><given-names>RW</given-names></name></person-group><article-title>Recombinational substrates designed to study recombination between unique and repetitive sequences in vivo</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1987</year><volume>84</volume><issue>17</issue><fpage>6215</fpage><lpage>6219</lpage><pub-id pub-id-type="pmid">3306671</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fung</surname><given-names>CW</given-names></name><name><surname>Mozlin</surname><given-names>AM</given-names></name><name><surname>Symington</surname><given-names>LS</given-names></name></person-group><article-title>Suppression of the double-strand-break-repair defect of the <italic>Saccharomyces cerevisiae</italic> rad57 mutant</article-title><source><italic>Genetics</italic></source><year>2009</year><volume>181</volume><issue>4</issue><fpage>1195</fpage><lpage>1206</lpage><pub-id pub-id-type="pmid">19189942</pub-id></element-citation></ref><ref id="B42"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Fasullo</surname><given-names>M</given-names></name></person-group><article-title>Multiple recombination pathways for sister chromatid exchange in <italic>Saccharomyces cerevisiae</italic>: role of RAD1 and the RAD52 epistasis group genes</article-title><source><italic>Nucleic Acids Research</italic></source><year>2003</year><volume>31</volume><issue>10</issue><fpage>2576</fpage><lpage>2585</lpage><pub-id pub-id-type="pmid">12736307</pub-id></element-citation></ref><ref id="B34"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lisby</surname><given-names>M</given-names></name><name><surname>Mortensen</surname><given-names>UH</given-names></name><name><surname>Rothstein</surname><given-names>R</given-names></name></person-group><article-title>Colocalization of multiple DNA double-strand breaks at a single Rad52 repair center</article-title><source><italic>Nature Cell Biology</italic></source><year>2003</year><volume>5</volume><issue>6</issue><fpage>572</fpage><lpage>577</lpage></element-citation></ref><ref id="B35"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egner</surname><given-names>PA</given-names></name><name><surname>Groopman</surname><given-names>JD</given-names></name><name><surname>Wang</surname><given-names>J-S</given-names></name><name><surname>Kensler</surname><given-names>TW</given-names></name><name><surname>Friesen</surname><given-names>MD</given-names></name></person-group><article-title>Quantification of aflatoxin-B<sub>1</sub>-N7-guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry</article-title><source><italic>Chemical Research in Toxicology</italic></source><year>2006</year><volume>19</volume><issue>9</issue><fpage>1191</fpage><lpage>1195</lpage><pub-id pub-id-type="pmid">16978023</pub-id></element-citation></ref><ref id="B36"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>CS</given-names></name><name><surname>Winston</surname><given-names>F</given-names></name></person-group><article-title>A ten-minute DNA preparation from yeast efficiently releases automomous plasmids for transformation of <italic>Escherichia coli</italic></article-title><source><italic>Gene</italic></source><year>1987</year><volume>57</volume><issue>2-3</issue><fpage>267</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">3319781</pub-id></element-citation></ref><ref id="B37"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foiani</surname><given-names>M</given-names></name><name><surname>Marini</surname><given-names>F</given-names></name><name><surname>Gamba</surname><given-names>D</given-names></name><name><surname>Lucchini</surname><given-names>G</given-names></name><name><surname>Plevani</surname><given-names>P</given-names></name></person-group><article-title>The B subunit of the DNA polymerase <italic>&#x003b1;</italic>-primase complex in Saccharomyces cerevisiae executes an essential function at the initial stage of DNA replication</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>1994</year><volume>14</volume><issue>2</issue><fpage>923</fpage><lpage>933</lpage><pub-id pub-id-type="pmid">8289832</pub-id></element-citation></ref><ref id="B38"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herzberg</surname><given-names>K</given-names></name><name><surname>Bashkirov</surname><given-names>VI</given-names></name><name><surname>Rolfsmeier</surname><given-names>M</given-names></name><etal/></person-group><article-title>Phosphorylation of Rad55 on serines 2, 8, and 14 is required for efficient homologous recombination in the recovery of stalled replication forks</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2006</year><volume>26</volume><issue>22</issue><fpage>8396</fpage><lpage>8409</lpage><pub-id pub-id-type="pmid">16966380</pub-id></element-citation></ref><ref id="B39"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lisby</surname><given-names>M</given-names></name><name><surname>Barlow</surname><given-names>JH</given-names></name><name><surname>Burgess</surname><given-names>RC</given-names></name><name><surname>Rothstein</surname><given-names>R</given-names></name></person-group><article-title>Choreography of the DNA damage response: spatiotemporal relationships among checkpoint and repair proteins</article-title><source><italic>Cell</italic></source><year>2004</year><volume>118</volume><issue>6</issue><fpage>699</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">15369670</pub-id></element-citation></ref><ref id="B40"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasullo</surname><given-names>M</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Zeng</surname><given-names>L</given-names></name></person-group><article-title>
						<italic>Saccharomyces cerevisiae</italic> RAD53 (CHK2) but not CHK1 is required for double-strand break-initiated SCE and DNA damage-associated SCE after exposure to X rays and chemical agents</article-title><source><italic>DNA Repair</italic></source><year>2005</year><volume>4</volume><issue>11</issue><fpage>1240</fpage><lpage>1251</lpage><pub-id pub-id-type="pmid">16039914</pub-id></element-citation></ref><ref id="B41"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toussaint</surname><given-names>M</given-names></name><name><surname>Conconi</surname><given-names>A</given-names></name></person-group><article-title>High-throughput and sensitive assay to measure yeast cell growth: a bench protocol for testing genotoxic agents</article-title><source><italic>Nature Protocols</italic></source><year>2006</year><volume>1</volume><issue>4</issue><fpage>1922</fpage><lpage>1928</lpage></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neecke</surname><given-names>H</given-names></name><name><surname>Lucchini</surname><given-names>G</given-names></name><name><surname>Longhese</surname><given-names>MP</given-names></name></person-group><article-title>Cell cycle progression in the presence of irreparable DNA damage is controlled by a Mec1- and Rad53-dependent checkpoint in budding yeast</article-title><source><italic>EMBO Journal</italic></source><year>1999</year><volume>18</volume><issue>16</issue><fpage>4485</fpage><lpage>4497</lpage><pub-id pub-id-type="pmid">10449414</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabbioneda</surname><given-names>S</given-names></name><name><surname>Bortolomai</surname><given-names>I</given-names></name><name><surname>Giannattasio</surname><given-names>M</given-names></name><name><surname>Plevani</surname><given-names>P</given-names></name><name><surname>Muzi-Falconi</surname><given-names>M</given-names></name></person-group><article-title>Yeast Rev1 is cell cycle regulated, phosphorylated in response to DNA damage and its binding to chromosomes is dependent upon MEC1</article-title><source><italic>DNA Repair</italic></source><year>2007</year><volume>6</volume><issue>1</issue><fpage>121</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">17035102</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pag&#x000e8;s</surname><given-names>V</given-names></name><name><surname>Santa Maria</surname><given-names>SR</given-names></name><name><surname>Prakash</surname><given-names>L</given-names></name><name><surname>Prakash</surname><given-names>S</given-names></name></person-group><article-title>Role of DNA damage-induced replication checkpoint in promoting lesion bypass by translesion synthesis in yeast</article-title><source><italic>Genes and Development</italic></source><year>2009</year><volume>23</volume><issue>12</issue><fpage>1438</fpage><lpage>1449</lpage><pub-id pub-id-type="pmid">19528320</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conde</surname><given-names>F</given-names></name><name><surname>Ontoso</surname><given-names>D</given-names></name><name><surname>Acosta</surname><given-names>I</given-names></name><name><surname>Gallego-S&#x000e1;nchez,</surname><given-names>A</given-names></name><name><surname>Bueno</surname><given-names>A</given-names></name><name><surname>San-Segundo</surname><given-names>PA</given-names></name></person-group><article-title>Regulation of tolerance to DNA alkylating damage by Dot1 and Rad53 in <italic>Saccharomyces cerevisiae</italic></article-title><source><italic>DNA Repair</italic></source><year>2010</year><volume>9</volume><issue>10</issue><fpage>1038</fpage><lpage>1049</lpage><pub-id pub-id-type="pmid">20674515</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>CB</given-names></name><name><surname>Lewis</surname><given-names>AL</given-names></name><name><surname>Baldwin</surname><given-names>KK</given-names></name><name><surname>Resnick</surname><given-names>MA</given-names></name></person-group><article-title>Lethality induced by a single site-specific double-strand break in a dispensable yeast plasmid</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1993</year><volume>90</volume><issue>12</issue><fpage>5613</fpage><lpage>5617</lpage><pub-id pub-id-type="pmid">8516308</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangavarapu</surname><given-names>V</given-names></name><name><surname>Prakash</surname><given-names>S</given-names></name><name><surname>Prakash</surname><given-names>L</given-names></name></person-group><article-title>Requirement of RAD52 group genes for postreplication repair of UV-damaged DNA in <italic>Saccharomyces cerevisiae</italic></article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2007</year><volume>27</volume><issue>21</issue><fpage>7758</fpage><lpage>7764</lpage><pub-id pub-id-type="pmid">17785441</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Rad53 checkpoint activation, cell cycle progression, and recombination after log-phase cells were exposed to 50&#x02009;<italic>&#x003bc;</italic>M AFB<sub>1</sub>. At indicated times, cells were collected for FACS analysis to measure frequencies of SCE and to make extracts to measure Rad53 activations. (a) Rad53 checkpoint activation was monitored after AFB<sub>1</sub> exposure at the indicated times. Rad53 and the activated checkpoint protein, Rad53p, are indicated by arrows. (b) FACS analysis was performed at indicated time periods after exposure. The G1 and G2 cells are indicated by P4 and P5. The peak to the right of the G2 peak indicates bloated cells due to enlarged vacuoles. (c) AFB<sub>1</sub>-associated SCE were measured by selecting for His<sup>+</sup> recombinants that result from unequal recombination between two truncated <italic>his3</italic> fragments. Net recombination frequencies = recombination frequency after AFB<sub>1</sub> exposure&#x02014;spontaneous recombination frequency.</p></caption><graphic xlink:href="JNA2010-456487.001"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Confocal imaging of Rad51-YFP foci in live AFB<sub>1</sub>-exposed yeast cells. (a) Control, no AFB<sub>1</sub> exposure, (b) Rad51-foci after exposure to X-rays, (c) Rad51 foci in logarithmically growing cells exposed to 50&#x02009;<italic>&#x003bc;</italic>M AFB<sub>1</sub>, wide view, and (d) Rad51 focus in a synchronized cell after alpha factor arrest and exposure to AFB<sub>1</sub>.</p></caption><graphic xlink:href="JNA2010-456487.002"/></fig><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Growth of wild type (a), <italic>rad51 </italic>(b),  <italic>rad4</italic> (e), and <italic>rad4 rad51</italic> (d) cells after exposure to AFB<sub>1</sub>. (Left) Growth of cells containing pCS316 and expressing CYP1A2 after chronic exposure to 0&#x02009;<italic>&#x003bc;</italic>M (black), 25&#x02009;<italic>&#x003bc;</italic>M (blue), and 50&#x02009;<italic>&#x003bc;</italic>M  (red) AFB<sub>1</sub>. The relevant genotype is given below the panel (see <xref ref-type="table" rid="tab1">Table 1</xref>, for complete genotype). 10<sup>5</sup>&#x02009;log-phase cells were inoculated in each well, <italic>n</italic> = 3.  <italic>A</italic><sub>600</sub> is plotted against time (h). (Right<italic>) rad4</italic> cells synchronized in G1 were exposed to 50&#x02009;<italic>&#x003bc;</italic>M AFB<sub>1</sub> for 3&#x02009;hrs, washed, and inoculated on YPD. Cell growth was monitored from 0&#x02013;18&#x02009;hrs. Bars indicate the actual range of measurements.</p></caption><graphic xlink:href="JNA2010-456487.003"/></fig><table-wrap id="tab1" position="float"><label>Table 1</label><caption><p>Yeast strains.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Strain (source)</th><th align="left" rowspan="1" colspan="1">Genotype</th><th align="center" rowspan="1" colspan="1">Plasmid introduced</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1">
							Strains isogenic to S288c*</td></tr><tr><td align="left" rowspan="1" colspan="1">YB401</td><td align="left" rowspan="1" colspan="1"><italic>MAT</italic>a-inc  <italic>ura3-52 his3- </italic>&#x00394;<italic>200  ade2-101 lys-801 trp1- </italic>&#x00394;<italic>1 gal3-trp1::  [his3- </italic>&#x00394;3&#x02032;<italic>::HOcs, his3- </italic>&#x00394;5&#x02032;<italic>] </italic></td><td align="center" rowspan="1" colspan="1">pCS316</td><td align="center" rowspan="1" colspan="1">This laboratory</td></tr><tr><td align="left" rowspan="1" colspan="1">YB402</td><td align="left" rowspan="1" colspan="1"><italic>MAT<italic>&#x003b1;</italic>  leu2-</italic>&#x00394;<italic>1 rad51</italic></td><td align="center" rowspan="1" colspan="1">pCS316</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B42">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">YB403</td><td align="left" rowspan="1" colspan="1"><italic>MAT</italic>a-inc <italic>ura3 rad4::KanMX </italic></td><td align="center" rowspan="1" colspan="1">pCS316</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B42">34</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">YB404</td><td align="left" rowspan="1" colspan="1"><italic>MAT</italic>a-inc <italic>ura3 rad51::URA3 rad4::KanMX rad51 </italic></td><td align="center" rowspan="1" colspan="1">pCS316</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B42">34</xref>] </td></tr><tr><td align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" colspan="4" rowspan="1">
							Strains isogenic to W303</td></tr><tr><td align="left" rowspan="1" colspan="1">YB405</td><td align="left" rowspan="1" colspan="1"><italic>MAT</italic>a <italic>YFP-rad51-I345T-URA3- </italic><break/><italic>RAD51 ADE2 leu2 trp1 ura3 his3 </italic></td><td align="center" rowspan="1" colspan="1">PRS424-CYP1A2</td><td align="center" rowspan="1" colspan="1">L.Symington (LSY1957) [<xref ref-type="bibr" rid="B33">33</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>*Strains under this heading are isogenic to S288c. All genotypes are the same as YB163, unless indicated.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" position="float"><label>Table 2</label><caption><p>AFB1-N<sup>7</sup> Guanine adducts in wild type and the <italic>rad4</italic> mutant.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Genotype (Strain)<sup>a</sup></th><th align="center" rowspan="1" colspan="1">Total AFB<sub>1</sub>-N<sup>7</sup>Guanine adducts/mg DNA<sup>b</sup></th><th align="center" rowspan="1" colspan="1">Ratio<sup>c</sup></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>RAD4</italic>  (YB163)</td><td align="center" rowspan="1" colspan="1">7.2 &#x000d7; 10<sup>&#x02212;3</sup>&#x02009;nmol</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>rad4</italic>::KanMX (YB225)</td><td align="center" rowspan="1" colspan="1">21.7 &#x000d7; 10<sup>&#x02212;3</sup>&#x02009;nmol</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Rad51-YFP (LSY1957)</td><td align="center" rowspan="1" colspan="1">4.6 &#x000d7; 10<sup>&#x02212;3</sup>&#x02009;nmol</td><td align="center" rowspan="1" colspan="1">0.7</td></tr></tbody></table><table-wrap-foot><fn><p>
						
						<sup>a</sup>Relevant genotype, see <xref ref-type="table" rid="tab1">Table 1</xref> for complete genotype,</p></fn><fn><p>
						
						<sup>b</sup><italic>n</italic> = 2,</p></fn><fn><p>
						
						<sup>c</sup>Ratio: AFB<sub>1</sub>   adduct in strain or <italic>rad</italic> mutant/AFB<sub>1</sub> adduct in wild type (YB163).</p></fn></table-wrap-foot></table-wrap></floats-group></article>